Please provide your email address to receive an email when new articles are posted on . FibroTest showed low accuracy in detecting significant fibrosis and cirrhosis among patients with chronic ...

Please provide your email address to receive an email when new articles are posted on . Researchers found transient elastography and FibroTest to be effective, noninvasive tools for hepatoxicity ...

In recent years the use of non-invasive biomarkers to assess liver fibrosis has become widely accepted. Although the combination of surrogate markers, such as those employed by the FibroTest, have a ...

At present, transient elastography and the serum marker FibroTest are the most intensively evaluated non-invasive methods for the assessment of liver fibrosis. The results of the present study for ...

Background: FibroTest (FT) is a biomarker of liver fibrosis initially validated in patients with chronic hepatitis C (CHC). The aim was to test two hypotheses, one, that the FT diagnostic value was ...

Noninvasive tests for liver fibrosis, such as liver stiffness measurement or the FibroTest, can predict survival of patients with chronic hepatitis C. Non-invasive tests for liver fibrosis, such as ...

Disease etiology is a major factor in the performance of noninvasive fibrosis biomarkers, according to new research published in Alimentary Pharmacology & Therapeutics. Moreover, the findings from ...

Non-invasive tests for liver fibrosis, such as liver stiffness measurement or the FibroTest, can predict survival of patients with chronic hepatitis C, according to a new study in Gastroenterology, ...